HopeStage
Back to overview

Depression studies

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 553-564 of 7,264
Drug study icon
RecruitingNCT06518720

A feasibility study of psilocybin therapy for nerve pain and depression

About this title

Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)

Read the official source — NCT06518720
Official study title

Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND): An Open-Label Clinical Trial

In Toronto
DepressionMedication studyAges 18–65
Countries
Canada
Sponsor
Centre for Addiction and Mental Health (Hospital / academic medical center)
Other study type icon
Not Yet RecruitingNCT07188753

Controlled study Testing the Efficacy of Transcranial Magnetic Stimulation by Accelerated & High-dose Theta-burst, Functional Imaging Guided, in the Treatment of Depression in Elderly Subjects With Cognitive Impairment

What is this study about?

This study evaluates the effectiveness of transcranial magnetic stimulation for people with depression.

This study isn't recruiting yet.

Location not clearly listed
DepressionPlacebo comparisonAges 65+
Countries
Sponsor
Rennes University Hospital

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.